Everolimus vs MMF: risks of pericardial effusion vs CAV

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1354, 2011-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib: Pericardial effusion and pleural effusion: case report

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Insulin: Pericardial effusion: case report

By  

Reactions Weekly, Vol. 1, Iss. 1437, 2013-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Elephants in the Room: Weighing the Benefits vs. the Risks of Antidepressant Treatment in Children

By  

Child and Adolescent Psychopharmacology News, Vol. 11, Iss. 4, 2006-06 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite

Cefuroxime vs a Dicloxacillin/Chloramphenicol Combination for the Treatment of Parapneumonic Pleural Effusion and Empyema in Children

By Palacios G.C.   Gonzalez S.N.   Perez F.L.   Cuevas S.F.   Solorzano S.F.  

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 1, 2002-01 ,pp. : 17-23

Academic Press

Access to resources Recommend Favorite

Docetaxel: Pericardial effusion: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1182, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite